⌕
Teladoc Health · TDOC · NYSE
Tenet 50 · Mixed
Compare
$8.70−1.14%At closeTenet 50 · Mixed
$8.70−0.10 (−1.14%)
At close: Nov 16, 2026, 4:00 PM ET· NYSE · USD

Teladoc Health (TDOC) Income Statement

Is this a real, growing, cash-generative business, or a story propped up by accounting?

Sources Company filings FilingsHow we compute thisNot investment advice
Business engineChoppy: revenue fell 1.5% in FY25, net margin −7.9%. Worth your attention in FY25: Share count (+12.3%). Visible in the receipts below.
The four lines that matter · FY21–FY25
Revenue ($M)▼1.5%
2,530.0
FY21→FY25CAGR +5.6%/yr
Net income ($M)▲80.0%
−200.3
one-off year: see footnoteCAGR —
Free cash flow ($M)▼1.6%
166.9
FY21→FY25CAGR +6.4%/yr
Diluted EPS▲80.6%
−1.14
FY21→FY25CAGR —
What the receipts whisper · what a headline number hides
Share count
+12.3%

156.9mn → 176.2mn diluted shares since FY21. Rising share count dilutes EPS. Growth must outrun it.

Capex
$127.5M

steady at 5.0% of revenue (+2.7% YoY).

What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)2530.0Revenue−771.6COGS1758.4Gross profit−277.9R&D−626.4SG&A−263.0Op income62.6Tax & other−200.3Net income

-8¢ of every revenue dollar becomes profit. The biggest cost lever is operating expenses.

Margin trend · direction beats level Gross Operating Net
806040200%sector median net margin ~4%FY21FY25

Over this window: gross 68.0% → 69.5%. Net margin -7.9% is below the sector median.

The receipt · income statement · FY21–FY25 USD millions except per-share & ratios · hover a line for its definition
USD millions except per-share & ratios
Line itemTTM †FY25FY24FY23FY22FY21YoYCAGR 21→25
Revenue & profitability
Revenue
2,468.12,530.02,569.62,602.42,406.82,032.7▼1.5%+5.6%
Cost of revenue
775.7771.6751.3760.0744.0650.3▲2.7%+4.4%
Gross profit
1,692.51,758.41,818.31,842.41,662.91,382.4▼3.3%+6.2%
Research & development
267.9277.9307.3348.5333.6311.9▼9.6%−2.8%
Selling, general & admin
619.9626.4640.5678.4677.0688.6▼2.2%−2.3%
Total operating expenses
1,855.42,021.32,839.22,090.915,316.11,648.1▼28.8%+5.2%
Operating incomefeeds ROC rank
−163.0−263.0−1,020.9−248.6−13,653.2−265.6▲74.2%—
Other income, net
4.327.427.228.9−10.1−119.0——
Pretax income
−158.7−235.5−993.7−219.6−13,663.3−384.7▲76.3%—
Income tax
−3.8−35.27.60.8−3.844.1——
Net incomePiotroski ROA ✕feeds Buffett Quality owner earnings
−154.8−200.3−1,001.2−220.4−13,659.5−428.8▲80.0%—
Per share
Diluted EPSbuyback-sensitive
−0.86−1.14−5.87−1.34−84.60−2.73▲80.6%—
Diluted shares (mn)
181.88176.22170.56164.58161.46156.94▲3.3%+2.9%
Margins
Gross margin53rd pct in Healthcare
68.6%69.5%70.8%70.8%69.1%68.0%▼1.3pp+1.5pp
Operating margin
−6.6%−10.4%−39.7%−9.6%−567.3%−13.1%▲29.3pp+2.7pp
Net margin30th pct in Healthcare
−6.3%−7.9%−39.0%−8.5%−567.5%−21.1%▲31.0pp+13.2pp
† TTM = trailing four quarters through 2026-09-30.FY21 effective tax rate was −11% vs a −0% norm for this window, likely a one-time item; see the filing.FY25 effective tax rate was 15% vs a −0% norm for this window, likely a one-time item; see the filing.
FY13 – FY20 · 8 more years
Unlock the full history →
5 more years of statements and CSV export are on Premium, and 8 more on Ultimate.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
Annual report filed 2026-02-26 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.

What was Teladoc Health's revenue last fiscal year?

Teladoc Health reported revenue of $2,530.0M in fiscal 2025, down 1.5% from fiscal 2024.

What was Teladoc Health's net income?

Teladoc Health reported net income of −$200.3M in fiscal 2025, a net margin of −7.9%.

Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.